Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Huber, K; Drexel, H; Alber, H; Auer, J; Fasching, P; Francesconi, C; Globits, S; Hodl, R; Hoppichler, F; Lang, W; Metzler, B; Podczeck-Schweighofer, A; Roithinger, FX; Schadler, T; Schernthaner, GH; Siostrzonek, P; Weidinger, F; Zweiker, R.
A practical approach for the implemantation of LDL-C lowering Guidelines 2017
J KARDIOL. 2017; 24(5-6): 94-100.
Web of Science

Co-authors Med Uni Graz: Zweiker Robert
Altmetrics:
Abstract:: "The lower, the better" principle for the reduction of LDL cholesterol (LDL-C) in patients with very high risk has gained confirmation by the data of PCSK9-inhibitors. Also current guidelines re-commend < 70 mg/dl as minimum target. Unfortunately, clinical routine in lipid lowering in Austria is far from recommended treatment goals. PCSK9-inhibition can be helpful in all instances where usual lipid lowering strategies are insufficient. The current publication aims to increase recent knowledge and to offer practical tips in order to contribute to optimal lipid lowering.
Find related publications in this database (Keywords): LDL cholesterol; LDL-C; PCSK9 inhibitors; guideline; Alirocumab; Evolocumab